as of 09-01-2026 4:00pm EST
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 631.4M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.10 | EPS Growth: | 23.94 |
| 52 Week Low/High: | $5.76 - $6.80 | Next Earning Date: | N/A |
| Revenue: | $502,729,000 | Revenue Growth: | 27.79% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -59.10 | Index: | N/A |
| Free Cash Flow: | -27787000.0 | FCF Growth: | N/A |
Director
Avg Cost/Share
$6.51
Shares
298,853
Total Value
$1,946,310.05
Owned After
411,976
SEC Form 4
10% Owner
Avg Cost/Share
$6.54
Shares
12,000
Total Value
$78,480.00
Owned After
10,660,858
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hively Brad | STLN | Director | Aug 21, 2026 | Sell | $6.51 | 298,853 | $1,946,310.05 | 411,976 | |
| Chernett Jorey | STLN | 10% Owner | Aug 14, 2026 | Buy | $6.54 | 12,000 | $78,480.00 | 10,660,858 |
SEC 8-K filings with transcript text
Aug 6, 2026
May 7, 2026
Mar 12, 2026
See how STLN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "STLN Starling Oncology Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.